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Coronary CT angiography and myocardial perfusion imaging to
detect flow-limiting stenoses: a potential gatekeeper for coronary
revascularization?
Abstract
Aims To evaluate the diagnostic accuracy of a combined non-invasive assessment of coronary artery
disease with coronary CT angiography (CTA) and myocardial perfusion imaging (MPI) for the detection
of flow-limiting coronary stenoses and its potential as a gatekeeper for invasive examination and
treatment. Methods and results In 78 patients (mean age 65 +/- 9 years) referred for coronary
angiography (CA), additional CTA and MPI (using single-photon emission-computed tomography)
were performed and the findings not communicated. Detection of flow-limiting stenoses (justifying
revascularization) by the combination of CTA and MPI (CTA/MPI) was compared with the combination
of quantitative coronary angiography (QCA) plus MPI (QCA/MPI), which served as standard of
reference. The findings of both combinations were related to the treatment strategy (revascularization
vs. medical treatment) chosen in the catheterization laboratory based on the CA findings. Sensitivity,
specificity, positive and negative predictive value, and accuracy of CTA/MPI for the detection of
flow-limiting coronary stenoses were 100% each. More than half of revascularization procedures (21/40,
53%) was performed in patients without flow-limiting stenoses and 76% (47/62) of revascularized
vessels were not associated with ischaemia on MPI. Conclusion The combined non-invasive approach
CTA/MPI has an excellent accuracy to detect flow-limiting coronary stenoses compared with QCA/MPI
and its use as a gatekeeper appears to make a substantial part of revascularization procedures redundant.
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ABSTRACT 
 
Aims To evaluate the diagnostic accuracy of a combined noninvasive assessment of 
coronary artery disease (CAD) with coronary CT angiography (CTA) and myocardial 
perfusion imaging (MPI) for the detection of flow-limiting coronary stenoses and its 
potential as a gatekeeper for invasive examination and treatment.   
Methods and results In 78 patients (mean age 65 ± 9 years) referred for coronary 
angiography (CA) additional CTA and MPI (using single photon emission computed 
tomography) were performed and the findings not communicated. Detection of flow-
limiting stenoses (justifying revascularization) by the combination of CTA and MPI 
(CTA/MPI) was compared to the combination of quantitative coronary angiography 
(QCA) plus MPI (QCA/MPI), which served as standard of reference. The findings of 
both combinations were related to the treatment strategy (revascularization versus 
medical treatment) chosen in the catheterization laboratory based on the CA findings. 
Sensitivity, specificity, positive and negative predictive value, and accuracy of 
CTA/MPI for the detection of flow-limiting coronary stenoses was 100% each. More 
than half of revascularization procedures (21/40, 53%) was performed in patients 
without flow-limiting stenoses and 76% (47/62) of revascularized vessels were not 
associated with ischemia on MPI.  
Conclusion The combined noninvasive approach CTA/MPI has an excellent 
accuracy to detect flow-limiting coronary stenoses compared to QCA/MPI and its use 
as a gatekeeper appears to make a substantial part of revascularization procedures 
redundant. 
 
Keywords coronary CT angiography, myocardial perfusion imaging, conventional 
coronary angiography, coronary artery disease 
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Introduction 
Over the past decades, many advances in imaging techniques have enhanced our 
pathophysiologic understanding of coronary artery disease (CAD). A comprehensive 
assessment of CAD should include both, information on coronary artery anatomy and 
functional information about the hemodynamic relevance of coronary artery lesions in 
order to guide revascularization procedures.1-3 In stable CAD, the debate on the role 
of elective percutaneous coronary intervention (PCI) is highly controversial.4,5 
Guidelines recommend proof of ischemia prior to elective revascularization of 
coronary stenoses,2,4,6 and several reports have demonstrated that PCI fails to 
improve prognosis in patients with stable CAD compared to conservative 
treatment.5,7 Nonetheless, in clinical practice, the decision to revascularize is often 
based solely upon visual angiographic criteria rather than objective proof of ischemia. 
Similarly, while quantitative coronary angiography (QCA) is commonly used as gold 
standard in clinical trials,8 its clinical role is limited as accurate analysis is generally 
not readily available during the procedure.  
Coronary multislice CT angiography (CTA) has evolved rapidly during the past 
decade allowing now visualization of coronary artery morphology and lesions with a 
temporal and spatial resolution that approaches conventional coronary angiography 
(CA).9,10 Combination of CTA and myocardial perfusion imaging (MPI) are 
noninvasive, and thus, allow noninvasive integrative assessment of CAD.11 Hence, it 
seems conceivable, that an early noninvasive assessment of CAD with CTA and 
SPECT may act as a gatekeeper for conventional coronary angiography and thus 
avoid unnecessary invasive diagnostic and revascularization procedures.  
 Therefore, the aim of the present study was to evaluate the diagnostic 
accuracy of the combination CTA/MPI versus QCA/MPI as a gatekeeper for invasive 
coronary examination and treatment. 
 - 3 - 
  
Methods  
 
Study population and study design 
We prospectively enrolled consecutive patients with known or suspected CAD 
referred to our institution for elective CA. The clinical decision to perform CA was 
based on the history and/or symptoms of the patient and/or on the results from 
exercise stress testing. Patients were eligible if they were in stable clinical condition 
i.e. if they were in Canadian Cardiac Society class I to III, and in New York Heart 
Association functional class I to III. Exclusion criteria were severe obstructive lung 
disease, high-grade atrioventricular conduction disturbances, atrial fibrillation, and 
known intolerance of iodinated contrast agents. Patients who agreed to participate 
underwent CTA and myocardial perfusion SPECT prior to the invasive procedure and 
the results from noninvasive testing were withheld from the interventional 
cardiologist. The study protocol was approved by the local institutional review board 
and all patients gave written informed consent before enrolment. All patients were 
made aware of the additional radiation dose from MPI and CTA prior to consent. The 
study population is shared with a prior publication by our group.12  
 
CTA image acquisition 
All scans were performed on a 64-slice CT scanner (Somatom Sensation 64; 
Siemens Medical Solutions, Forchheim, Germany). Patients with pre-scan heart rates 
above 70 beats pre minute (bpm) received intravenous beta-blocker therapy (5-15 
mg metoprolol) immediately prior to the CT scan. Low-dose calcium score, helical 
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CTA scanning, and image reconstruction parameters were used as previously 
reported.12,13  
 
CTA image interpretation 
CTA image interpretation was performed on axial source images, multiplanar and 
curved reformations, and thin-slab maximum intensity projections. First, image quality 
for each data set was rated by one reader on a scale ranging from score 1 (excellent 
image quality), 2 (good image quality), 3 (moderate image quality), 4 (poor, but still 
diagnostic image quality), to score 5 (very poor image quality, nonevaluable data set 
defined as having at least one nonevaluable segment). Coronary arteries were 
subdivided according to a 15-segment model proposed by the American Heart 
Association.14 
Then, each segment was visually evaluated on at least two planes, one 
parallel and one perpendicular to the course of the vessel with regard to coronary 
artery delineation. On these images, the degree of diameter stenosis was 
qualitatively graded by two independent readers (who were both blinded to the 
clinical history and to the findings from MPI and CA) on a decimal scale in 10% steps 
from 0% to 100%. The ultimate diameter stenosis was calculated as the mean of 
both measurements. A significant stenosis was defined as narrowing of the coronary 
lumen ≥ 50%, and all vessels with a diameter down to 1.5 mm were included in the 
analysis. 
 
MPI image acquisition 
SPECT image acquisition was performed using a one-day electrocardiographically 
(ECG)-gated stress/rest protocol with adenosine stress (140 μg/kg/min) and 99mTc-
tetrofosmin (250 to 350 MBq at peak stress and 3 times the stress dose at rest 
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according to standard protocol).15 Scanning parameters and image reconstruction 
algorithms were applied as previously reported.12 Patients were told to refrain from 
caffeine-containing beverages for at least 12 hours, nitrates and calcium channel 
blockers 24 hours, and betablockers 48 hours before the MPI study.  
 
MPI image interpretation 
SPECT image interpretation was visually performed by consensus of two 
experienced nuclear cardiologists on short axis, horizontal long axis, and vertical long 
axis slices, and semiquantitative polar maps of perfusion using previously validated 
automated software.16 Anterior and septal wall perfusion defects were allocated to 
the left anterior descending coronary artery (LAD), lateral defects to the left 
circumflex coronary artery (LCX), and inferior defects to the right coronary artery 
(RCA). Reversible perfusion defects were considered to represent myocardial 
ischemia. Fixed perfusion defects with concomitant regional wall motion 
abnormalities were considered to be myocardial scars.17  
 
Quantitative coronary angiography 
Biplane conventional CA was performed according to standard techniques and 
evaluated by an experienced observer who was blinded to the results from CTA and 
MPI. QCA measurements were performed on two different image planes using an 
automated edge-detection system (Xcelera 1.2, Philips Medical Systems, Best, The 
Netherlands) as previously described.12 A significant stenosis was defined as a 
diameter reduction of ≥ 50%. 
 
Comparison of CTA and QCA 
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The diagnostic accuracy of CTA was assessed by comparison to the results from 
QCA, which was considered to be the gold standard for coronary stenosis evaluation. 
Comparison was performed on an intention-to-diagnose basis and therefore, 
nonevaluable segments on CTA were considered as positives. 
 
Assessment of flow-limiting coronary stenoses 
A flow-limiting coronary stenosis was defined as a lesion with a diameter narrowing 
exceeding 50% (on CTA or on QCA) inducing a reversible perfusion defect in its 
subtending myocardial territory on MPI (myocardial ischemia) (Fig. 1). A coronary 
stenosis of ≥ 50% without any associated myocardial ischemia was considered to be 
non-flow-limiting. Conversely, a reversible perfusion defect in a territory subtended by 
a nonstenotic coronary artery was considered to represent a false positive MPI result. 
As shown in Figure 1, the presence or absence of flow-limiting coronary stenosis was 
assessed independently for the combination of CTA plus MPI (CTA/MPI) and for the 
combination of QCA plus MPI (QCA/MPI), the latter being considered the gold 
standard for a combined assessment of coronary morphology and hemodynamic 
lesion severity. 
 
Coronary revascularizations 
Coronary revascularization procedures included PCI with or without stent 
implantation and coronary artery bypass grafting (CABG). According to guidelines, a 
stenosis was considered as an indication for revascularization only if it was 
associated with a reversible perfusion defect on MPI (flow-limiting stenosis). Finally, 
the patients’ actual treatment strategy (revascularization versus medical treatment) 
was compared to the imaging-derived treatment recommendations, on patient- and 
vessel-based analysis. 
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 Statistical analysis 
Statistical analysis was performed using the SPSS software package (SPSS 12.0.1 
for Windows, SPSS Corp.). Quantitative data are expressed as mean ± SD (unless 
otherwise stated) and categorical data given in proportions and percentages. 
Statistical comparison of quantitative data was performed using an unpaired two-
tailed student’s t-test  or Mann-Whitey U test where appropriate and comparison of 
categorical data using a chi-squared test with Yates’ correction or McNemar’s test for 
comparison of paired proportions. A p value < 0.05 was considered statistically 
significant for all tests. Pretest CAD likelihood was calculated according to Diamond 
and Forrester.18 Sensitivity, specificity, positive (PPV), and negative predictive value 
(NPV), and accuracy were obtained from 2x2 contingency tables and their respective 
95% confidence intervals (CI) calculated from binomial expression. Accuracy was 
determined as the percentage of correct diagnoses in the entire sample. Univariate 
logistic regression was used to identify predictors for revascularization and the 
regression results are presented as odds ratios (OR) and their respective 95 % CIs. 
Additionally, multivariate logistic regression was applied to identify independent 
predictors by including all factors with p < 0.05 and correction for the baseline 
characteristics with p < 0.1 on univariate analysis. 
 
 
Results 
 
Ninety-six patients were enrolled in the study, of which 18 (19%) had to be excluded: 
No CTA (n = 7) due to atrial fibrillation or technical reasons, no CA (n = 11) due to 
rescheduling, consent withdrawal, clinical deterioration and logistic reasons. The final 
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analysis included 78 patients with a mean age of 65  9 years (range, 40 to 87 years) 
(35 (45%) female) (Table 1). The median time interval between CTA and MPI was 0 
days (range, 0 to 26 days), between CTA and CA one day (range, 0 to 22 days), and 
between MPI and CA one day (range, 0 to 26 days). A delay of more than 2 weeks 
between CTA and MPI was found in only 1 patient, and between CTA/MPI and CA in 
5 patients. 
 
CTA results 
All patients were in stable sinus rhythm and the mean heart rate during the CT scan 
was 62  9 bpm. Ten patients (13%) were pretreated with intravenous metoprolol.  
A total number of 1093 coronary segments in 310 main coronary arteries were 
analyzed. In 2 patients the left main coronary artery (LMA) was missing as LAD and 
LCX had separate origins from the left coronary sinus. The mean image quality score 
was 2.9  0.9. Image quality scores were 1 in 1 (1%) patient, 2 in 31 (40%) patients, 
3 in 26 (33%) patients, 4 in 15 (19%) patients, and 5 in 5 (6%) patients. Eight (1%) 
coronary segments were not evaluable because of motion artefacts (n = 2), heavy 
calcifications (n = 1), or both (n = 5). On intention-to-diagnose basis, visual CTA 
image analysis revealed a stenosis in 137/1093 (13%) segments corresponding to 
91/310 (29%) coronary arteries in 46/78 (59%) patients (Fig. 2). The details of the 
CTA results are given in Table 2. Interreader agreement for stenosis detection on 
CTA was 92% (95% CI, 90 – 93%) on segment-based analysis. 
 
MPI results 
Image quality of MPI was amenable to visual interpretation in all the 78 patients. 
Visual image analysis revealed 14 reversible, 13 fixed, and 6 partially reversible 
perfusion defects in 31/78 (40%) patients (Table 2). The distribution of the perfusion 
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defects among the different coronary artery territories was as follows: reversible 
perfusion defects: LAD (n = 8), LCX (n = 2), RCA (n = 4); fixed perfusion defects: 
LAD (n = 4), LCX (n = 3), RCA (n = 6); partially reversible perfusion defects: LAD (n = 
1), LCX (n = 1), RCA (n = 4). 
 
CA results 
QCA analysis of biplane CA revealed stenoses (of ≥ 50% diameter stenosis) in 
92/310 (30%) coronary arteries corresponding to 49/78 (63%) patients. As with CTA, 
the LMA was missing in 2 patients as LAD and LCX had separate origins from the left 
coronary sinus. The details of the QCA results are given in Table 2.  
 
Comparison of CTA versus QCA 
Sensitivity, specificity, PPV, NPV, and accuracy of CTA for the detection of coronary 
stenoses on QCA was 88% (95% CI, 80 – 94%), 95% (92 – 98%), 89% (81 – 95%), 
95% (91 – 97%), and 93% (90 – 96%), respectively on vessel-based analysis, and 
94% (83 – 99%), 100% (88 – 100%), 100% (92 – 100%), 91% (75 – 98%), and 96% 
(89 – 99%), respectively on patient-based analysis.  
 
Assessment of flow-limiting stenoses 
On both combined analyses of CTA/MPI as well as QCA/MPI 19/78 (24%) patients 
had flow-limiting stenoses. Eight stenoses were localized in the LAD-, 2 in the LCX-, 
and 9 in the RCA-territory. Sensitivity, specificity, PPV, NPV, and accuracy of the 
combination CTA/MPI for the detection of flow-limiting coronary stenoses on 
QCA/MPI was 100% (95% CI, 82 – 100%), 100% (99 – 100%), 100% (82 – 100%), 
100% (99 – 100%), and 100% (99 – 100%), respectively on vessel-based analysis, 
and 100% (82 – 100%), 100% (94 – 100%), 100% (82 – 100%), 100% (94 – 100%), 
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and 100% (95 – 100%), respectively on patient-based analysis. When including fixed 
perfusion defects into the analysis, the PPV of MPI was 85% with a clear trend 
towards improvement after addition of CTA (96%) although the difference fell short of 
statistical significance (p=0.07).  
 
Revascularizations 
A revascularization procedure was performed in 40/78 (51%) patients of whom 11/78 
(14%) underwent CABG and 29/78 (37%) PCI (with stenting in all but one patients). 
The median time interval between CA and revascularization procedure was 0 days 
(range, 0 – 51 days), all PCI procedures were performed ad hoc. On vessel-based 
analysis, 62/310 (20%) coronary arteries were revascularized (LMA, n = 2; LAD, n = 
23; LCX, n = 21; RCA, n = 16). 
 Figure 3 shows the study population subcategorized according to the 
presence or absence of flow-limiting stenoses on CTA/MPI or QCA/MPI and the 
treatment strategy (revascularization versus medical treatment) on patient- and 
vessel-based analysis. Typical angina was present in 21 (53%) and 9 (24%) patients 
(p = 0.02) in the revascularization and medical group, respectively, and a 
pathological exercise test in 16 (40%) and 19 (50%) patients, respectively (p = 0.51). 
However, an exercise test was only performed in 44 (56%) of patients. Among the 21 
patients without flow-limiting stenoses undergoing revascularization the prevalence of 
symptoms was: typical angina, 25% (10/21): atypical chest pain, 5% (2/21); dyspnea, 
10% (4/21);  and no symptoms, 13% (5/21) (p = NS compared to patients without 
flow-limiting stenoses and medical treatment). 
All patients with flow-limiting stenoses were revascularized. However, more 
than half of revascularization procedures (21/40, 53%) were performed in patients 
without flow-limiting stenoses and 76% (47/62) of revascularized vessels were not 
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associated with ischemia on MPI (Figure 4). Nineteen percent (4/21) of 
revascularization procedures in patients without flow-limiting stenoses were CABG 
and 81% (17/21) ad hoc PCIs. The fraction of CABG among patients without flow-
limiting stenoses tended to be lower than in patients with flow-limiting stenoses (19% 
versus 37%, p = NS). In patients with no flow-limiting stenoses there were no 
differences in baseline characteristics between those undergoing revascularization (n 
= 21) and those treated medically (n = 38) except for a higher prevalence of known 
CAD in the former group (62% versus 13%, p < 0.001).  
 Significant clinical predictors of revascularization by univariate logistic 
regression were a history of CAD, the presence of typical angina, history of diabetes 
mellitus and current or former smoking status (Table 3). Multivariate logistic 
regression analysis identified a history of diabetes mellitus as the only independent 
predictor of revascularization.  
  
 
Discussion 
 
Our study documents an excellent ability of a combined noninvasive approach with 
CTA and MPI using SPECT for detecting flow-limiting coronary stenoses compared 
to the gold standard of QCA combined with MPI. In all patients with flow-limiting 
coronary stenoses (i.e. stenoses that were associated with myocardial ischemia as 
evidenced by MPI) a revascularization procedure was performed. However, half of 
patients undergoing revascularization lacked any flow-limiting coronary stenoses 
based on noninvasive imaging and almost three quarters of revascularized vessels 
were not associated with myocardial ischemia. These findings underline a potential 
role of a combined noninvasive assessment with CTA and MPI as a gatekeeper for 
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revascularization procedures in order to avoid its overuse and the associated burden 
of periprocedural morbidity. By doing so, in our study population in 21/78 (27%) 
patients an unnecessary revascularization procedure might have been prevented, 
while in none of the patients a revascularization procedure would have been falsely 
withheld.  
 The role of revascularization procedures in patients with stable CAD is 
controversial. As with medical therapy, the objectives of coronary revascularization 
procedures are two-fold, to improve survival free of ischemic events, and to diminish 
or eradicate ischemic symptoms.4 Since the highest risk patients derive the highest 
benefit from revascularization procedures, both the individual risk of the patient as 
well as his symptomatic status must be a major determinant in the decision-making 
process. High risk factors include high risk angiographical configuration (LMA 
disease, proximal three-vessel disease), impaired left ventricular function, 
pronounced symptoms (angina CCS III-IV), or the presence of myocardial ischemia 
by noninvasive testing.19 Coronary revascularization procedures have convincingly 
shown to reduce ischemic symptoms and improve quality of life even in patients at 
low risk.7 However, periprocedural morbidity and mortality remain important 
considerations. In fact, in a stable CAD population coronary revascularization 
procedures have failed to demonstrate an improvement in prognosis compared to 
state-of-the-art medical therapy.5,7,19,20 Therefore, guidelines recommend proof of 
ischemia prior to revascularization procedures.2,4 If moderate to large ischemia is 
present, however, a coronary revascularization may actually improve prognosis 
compared to medical treatment21 by a more effective reduction in the amount of 
jeopardized myocardium.22 On the other hand, revascularization of a non-flow-limiting 
coronary stenosis is not of benefit for the patient, neither from a prognostic nor from a 
symptomatic point of view.23,24  
 - 13 - 
Therefore, MPI has been suggested as gatekeeper for invasive examination.25 
However, combining  MPI with CTA has been shown to improve the accuracy of 
noninvasive assessment,26 as false positive MPI findings may be disproved by 
negative CTA which may be of particular importance in low CAD prevalence 
populations. In addition, not every flow-limiting lesion may be suitable for PCI, which 
may be identified by CTA avoiding futile invasive attempts. Interestingly, only 56% of 
patients in our non-selected study population had undergone a stress ECG prior to 
CA, and in less than half of patients the stress ECG was pathologic. However, 
patients in the revascularization group had a higher prevalence of angina pectoris. 
This may explain why a considerable amount of presumably non-flow-limiting lesions 
were nevertheless revascularized, as 87% of these patients had symptoms. This 
reflects that in clinical reality a decision to revascularize often also incorporates the 
overall presentation and symptoms of a patient. Of note, the vast majority of these 
revascularization procedures were ad hoc PCIs. This observation is in line with 
previous publications reporting that 66% of PCIs are ad hoc procedures in stable 
CAD patients.27 
Several factors may contribute to the observed discrepancy between 
guidelines and the use of PCI in real life, among them insufficient use of noninvasive 
testing, and potential medicolegal considerations (presumably not allowing a 
detected stenosis untreated). The latter may be driven by the open artery theory, 
although not supported by latest results.28 In fact, previous reports have documented 
a high correlation between catheterization and revascularization rates.29 Our results 
suggest the use of a combined noninvasive approach with CTA and MPI prior to 
coronary revascularization as a method to help providers more fully incorporate 
clinical evidence into their decision-making process. Additionally, a comprehensive 
noninvasive assessment of CAD with CTA and MPI would allow for careful selection 
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of the optimal revascularization procedure according to the guidelines improving the 
balance between periprocedural risk and prognostic benefit for each individual 
patient.  
 
Study limitations 
An important drawback of noninvasive cardiac imaging is the high radiation exposure 
associated with CTA and MPI. In fact, studies with 64-slice CTA reported an 
estimated radiation burden of upto 21.4 mSv without the use of ECG-pulsing30 and 
MPI-SPECT studies with 99mTc-based radiotracers are associated with radiation 
doses in the range of 9 – 11 mSv.31 However, with the implementation of prospective 
ECG-gating protocols for CTA, radiation exposure can be reduced down to 2.1 
mSv32,33 and alternative MPI techniques such as positron emission tomography with 
13N-ammonia or 15O-water may reduce radiation placing the resuting radiation 
exposure well within the range of conventional CA. Additionally, hybrid imaging 
combining CTA using prospective ECG gating with stress-only SPECT has been 
suggested as an attractive alternative to standard stress/rest SPECT for the 
detection of CAD reducing radiation exposure to 5.4 mSv.34 
 In the present study we have defined flow-limiting stenoses as 
angiographically determined coronary narrowings associated with a reversible 
perfusion defect in the subtended myocardial territory. The perfusion defect was 
assessed by SPECT MPI, a method which may be limited to accurately localize 
ischemia-producing lesions in patients with multivessel CAD.35 Thus, in these 
patients, determining which lesions warrant stenting can be difficult. This may 
potentially be overcome by invasively assessed fractional flow reserve.24 Whether 
alternative measures such as for instance cardiac magnetic resonance imaging with 
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an in-plane resolution superior to SPECT may help solving this issue, remains to be 
determined.  
Another shortcoming of our study was the limited number of study participants. 
As a result, no significant increments in diagnostic accuracy with CTA/MPI compared 
to MPI alone were observed. Furthermore, it was not possible to perform subgroup 
analysis across different patient strata such as patients with multivessel versus 
patients with single vessel disease. In addition, the study was not designed to assess 
the clinical follow up. Therefore, a potential improvement in clinical symptomatology 
justifying the revascularization was possibly missed.   
 
 
Conclusions 
 
The combined noninvasive approach with CTA and MPI in patients with known or 
suspected CAD has an excellent accuracy to detect flow-limiting coronary stenoses 
compared to the gold standard of QCA combined with MPI and may be used as a 
gatekeeper for CA and revascularization procedures. 
 - 16 - 
Acknowledgements 
This study was supported by an European Society of Cardiology (ESC) research 
grant (O.G.), by a grant from the Swiss National Science Foundation (P.A.K.) and by 
a grant of the National Center of Competence in Research, Computer Aided and 
Image Guided Medical Interventions (NCCR CO-ME) of the Swiss National Science 
Foundation (H.A.).  
 - 17 - 
References 
 
1. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The 
dissociation between clinical and angiographic findings in ischemic heart 
disease. Circulation 1995;92:2333-2342. 
2. Smith SC, Jr., Feldman TE, Hirshfeld JW, Jr., Jacobs AK, Kern MJ, King SB, 
3rd, Morrison DA, O'Neill WW, Schaff HV, Whitlow PL, Williams DO, Antman 
EM, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, 
Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/SCAI 2005 
guideline update for percutaneous coronary intervention: a report of the 
American College of Cardiology/American Heart Association Task Force on 
Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 
Guidelines for Percutaneous Coronary Intervention). J Am Coll Cardiol 
2006;47:e1-121. 
3. White CW, Wright CB, Doty DB, Hiratza LF, Eastham CL, Harrison DG, 
Marcus ML. Does visual interpretation of the coronary arteriogram predict the 
physiologic importance of a coronary stenosis? N Engl J Med 1984;310:819-
824. 
4. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De 
Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, 
Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, 
Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Osterspey 
A, Tamargo J, Zamorano JL. Guidelines on the management of stable angina 
pectoris: executive summary: the Task Force on the Management of Stable 
Angina Pectoris of the European Society of Cardiology. Eur Heart J 
2006;27:1341-1381. 
5. Boden WE, O'Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, 
Knudtson M, Dada M, Casperson P, Harris CL, Chaitman BR, Shaw L, 
Gosselin G, Nawaz S, Title LM, Gau G, Blaustein AS, Booth DC, Bates ER, 
Spertus JA, Berman DS, Mancini GB, Weintraub WS. Optimal medical therapy 
with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-
1516. 
6. Gibbons RJ, Abrams J, Chatterjee K, Daley J, Deedwania PC, Douglas JS, 
Ferguson TB, Jr., Fihn SD, Fraker TD, Jr., Gardin JM, O'Rourke RA, 
 - 18 - 
Pasternak RC, Williams SV. ACC/AHA 2002 guideline update for the 
management of patients with chronic stable angina--summary article: a report 
of the American College of Cardiology/American Heart Association Task Force 
on practice guidelines (Committee on the Management of Patients With 
Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-168. 
7. Bucher HC, Hengstler P, Schindler C, Guyatt GH. Percutaneous transluminal 
coronary angioplasty versus medical treatment for non-acute coronary heart 
disease: meta-analysis of randomised controlled trials. BMJ 2000;321:73-77. 
8. Windecker S, Remondino A, Eberli FR, Juni P, Raber L, Wenaweser P, Togni 
M, Billinger M, Tuller D, Seiler C, Roffi M, Corti R, Sutsch G, Maier W, Luscher 
T, Hess OM, Egger M, Meier B. Sirolimus-eluting and paclitaxel-eluting stents 
for coronary revascularization. N Engl J Med 2005;353:653-662. 
9. Leschka S, Alkadhi H, Plass A, Desbiolles L, Grunenfelder J, Marincek B, 
Wildermuth S. Accuracy of MSCT coronary angiography with 64-slice 
technology: first experience. Eur Heart J 2005;26:1482-1487. 
10. Scheffel H, Alkadhi H, Plass A, Vachenauer R, Desbiolles L, Gaemperli O, 
Schepis T, Frauenfelder T, Schertler T, Husmann L, Grunenfelder J, Genoni 
M, Kaufmann PA, Marincek B, Leschka S. Accuracy of dual-source CT 
coronary angiography: First experience in a high pre-test probability population 
without heart rate control. Eur Radiol 2006;16:2739-2747. 
11. Gaemperli O, Schepis T, Valenta I, Husmann L, Scheffel H, Duerst V, Eberli 
FR, Luscher TF, Alkadhi H, Kaufmann PA. Cardiac image fusion from stand-
alone SPECT and CT: clinical experience. J Nucl Med 2007;48:696-703. 
12. Gaemperli O, Schepis T, Valenta I, Koepfli P, Husmann L, Scheffel H, 
Leschka S, Eberli FR, Luscher TF, Alkadhi H, Kaufmann PA. Functionally 
relevant coronary artery disease: comparison of 64-section CT angiography 
with myocardial perfusion SPECT. Radiology 2008;248:414-423. 
13. Husmann L, Leschka S, Desbiolles L, Schepis T, Gaemperli O, Seifert B, 
Cattin P, Frauenfelder T, Flohr TG, Marincek B, Kaufmann PA, Alkadhi H. 
Coronary artery motion and cardiac phases: dependency on heart rate -- 
implications for CT image reconstruction. Radiology 2007;245:567-576. 
14. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon 
DC, Murphy ML, Roe BB. A reporting system on patients evaluated for 
coronary artery disease. Report of the Ad Hoc Committee for Grading of 
 - 19 - 
Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart 
Association. Circulation 1975;51:5-40. 
15. Hesse B, Tagil K, Cuocolo A, Anagnostopoulos C, Bardies M, Bax J, Bengel 
F, Busemann Sokole E, Davies G, Dondi M, Edenbrandt L, Franken P, Kjaer 
A, Knuuti J, Lassmann M, Ljungberg M, Marcassa C, Marie PY, McKiddie F, 
O'Connor M, Prvulovich E, Underwood R, van Eck-Smit B. EANM/ESC 
procedural guidelines for myocardial perfusion imaging in nuclear cardiology. 
Eur J Nucl Med Mol Imaging 2005;32:855-897. 
16. Germano G, Kavanagh PB, Waechter P, Areeda J, Van Kriekinge S, Sharir T, 
Lewin HC, Berman DS. A new algorithm for the quantitation of myocardial 
perfusion SPECT. I: technical principles and reproducibility. J Nucl Med 
2000;41:712-719. 
17. Fleischmann S, Koepfli P, Namdar M, Wyss CA, Jenni R, Kaufmann PA. 
Gated (99m)Tc-tetrofosmin SPECT for discriminating infarct from artifact in 
fixed myocardial perfusion defects. J Nucl Med 2004;45:754-759. 
18. Diamond GA, Forrester JS. Analysis of probability as an aid in the clinical 
diagnosis of coronary-artery disease. N Engl J Med 1979;300:1350-1358. 
19. Yusuf S, Zucker D, Peduzzi P, Fisher LD, Takaro T, Kennedy JW, Davis K, 
Killip T, Passamani E, Norris R, et al. Effect of coronary artery bypass graft 
surgery on survival: overview of 10-year results from randomised trials by the 
Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 
1994;344:563-570. 
20. Pitt B, Waters D, Brown WV, van Boven AJ, Schwartz L, Title LM, Eisenberg 
D, Shurzinske L, McCormick LS. Aggressive lipid-lowering therapy compared 
with angioplasty in stable coronary artery disease. Atorvastatin versus 
Revascularization Treatment Investigators. N Engl J Med 1999;341:70-76. 
21. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison 
of the short-term survival benefit associated with revascularization compared 
with medical therapy in patients with no prior coronary artery disease 
undergoing stress myocardial perfusion single photon emission computed 
tomography. Circulation 2003;107:2900-2907. 
22. Shaw LJ, Berman DS, Maron DJ, Mancini GB, Hayes SW, Hartigan PM, 
Weintraub WS, O'Rourke RA, Dada M, Spertus JA, Chaitman BR, Friedman J, 
Slomka P, Heller GV, Germano G, Gosselin G, Berger P, Kostuk WJ, 
Schwartz RG, Knudtson M, Veledar E, Bates ER, McCallister B, Teo KK, 
 - 20 - 
Boden WE. Optimal medical therapy with or without percutaneous coronary 
intervention to reduce ischemic burden: results from the Clinical Outcomes 
Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial 
nuclear substudy. Circulation 2008;117:1283-1291. 
23. Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van't 
Veer M, Bar F, Hoorntje J, Koolen J, Wijns W, de Bruyne B. Percutaneous 
coronary intervention of functionally nonsignificant stenosis: 5-year follow-up 
of the DEFER Study. J Am Coll Cardiol 2007;49:2105-2111. 
24. Tonino PA, De Bruyne B, Pijls NH, Siebert U, Ikeno F, van' t Veer M, Klauss 
V, Manoharan G, Engstrom T, Oldroyd KG, Ver Lee PN, MacCarthy PA, 
Fearon WF. Fractional flow reserve versus angiography for guiding 
percutaneous coronary intervention. N Engl J Med 2009;360:213-224. 
25. Hoilund-Carlsen PF, Johansen A, Christensen HW, Vach W, Moldrup M, 
Bartram P, Veje A, Haghfelt T. Potential impact of myocardial perfusion 
scintigraphy as gatekeeper for invasive examination and treatment in patients 
with stable angina pectoris: observational study without post-test referral bias. 
Eur Heart J 2006;27:29-34. 
26. Rispler S, Keidar Z, Ghersin E, Roguin A, Soil A, Dragu R, Litmanovich D, 
Frenkel A, Aronson D, Engel A, Beyar R, Israel O. Integrated single-photon 
emission computed tomography and computed tomography coronary 
angiography for the assessment of hemodynamically significant coronary 
artery lesions. J Am Coll Cardiol 2007;49:1059-1067. 
27. Cook S, Walker A, Hugli O, Togni M, Meier B. Percutaneous coronary 
interventions in Europe: prevalence, numerical estimates, and projections 
based on data up to 2004. Clin Res Cardiol 2007;96:375-382. 
28. Hochman JS, Lamas GA, Buller CE, Dzavik V, Reynolds HR, Abramsky SJ, 
Forman S, Ruzyllo W, Maggioni AP, White H, Sadowski Z, Carvalho AC, 
Rankin JM, Renkin JP, Steg PG, Mascette AM, Sopko G, Pfisterer ME, Leor J, 
Fridrich V, Mark DB, Knatterud GL. Coronary intervention for persistent 
occlusion after myocardial infarction. N Engl J Med 2006;355:2395-2407. 
29. Verrilli D, Welch HG. The impact of diagnostic testing on therapeutic 
interventions. JAMA 1996;275:1189-1191. 
30. Mollet NR, Cademartiri F, van Mieghem CA, Runza G, McFadden EP, Baks T, 
Serruys PW, Krestin GP, de Feyter PJ. High-resolution spiral computed 
 - 21 - 
tomography coronary angiography in patients referred for diagnostic 
conventional coronary angiography. Circulation 2005;112:2318-2323. 
31. Einstein AJ, Moser KW, Thompson RC, Cerqueira MD, Henzlova MJ. 
Radiation dose to patients from cardiac diagnostic imaging. Circulation 
2007;116:1290-1305. 
32. Husmann L, Valenta I, Gaemperli O, Adda O, Treyer V, Wyss CA, Veit-
Haibach P, Tatsugami F, von Schulthess GK, Kaufmann PA. Feasibility of low-
dose coronary CT angiography: first experience with prospective ECG-gating. 
Eur Heart J 2008;29:191-197. 
33. Herzog BA, Husmann L, Valenta I, Tay FM, Burkhard N, Gaemperli O, Wyss 
CA, Landmesser U, Kaufmann PA. Determinants of vessel contrast in BMI-
adapted low dose CT coronary angiography with prospective ECG-triggering. 
Int J Cardiovasc Imaging 2009. 
34. Husmann L, Herzog BA, Gaemperli O, Tatsugami F, Burkhard N, Valenta I, 
Veit-Haibach P, Wyss CA, Landmesser U, Kaufmann PA. Diagnostic accuracy 
of computed tomography coronary angiography and evaluation of stress-only 
single-photon emission computed tomography/computed tomography hybrid 
imaging: comparison of prospective electrocardiogram-triggering vs. 
retrospective gating. Eur Heart J 2009;30:600-607. 
35. Lima RS, Watson DD, Goode AR, Siadaty MS, Ragosta M, Beller GA, 
Samady H. Incremental value of combined perfusion and function over 
perfusion alone by gated SPECT myocardial perfusion imaging for detection of 
severe three-vessel coronary artery disease. J Am Coll Cardiol 2003;42:64-70. 
 
 
 - 22 - 
Tables 
 
Table 1 Patient Characteristics 
 All patients  
(n = 78) 
Revasc group
(n = 40) 
Medical group 
(n = 38) 
p-value* 
Age (years) 65  9 66  8 63  10 0.18 
Female gender, n (%) 35 (45%) 13 (33%) 22 (58%) 0.02 
Body mass index (kg/m2) 26  4 27  4 26  4 0.37 
Systolic blood pressure (mmHg) 134   19 135  19 132  19 0.47 
Diastolic blood pressure (mmHg) 78  12 77  11 80  12 0.35 
Total serum cholesterol (mmol/l) 4.8  1.0 4.7  0.9 4.9  1.1 0.32 
Cardiovascular history, n (%)     
 Known CAD 19 (24%) 14 (35%) 5 (13%) 0.02 
  Single-vessel CAD 5 (6%) 3 (8%) 2 (5%) 0.69 
  Two-vessel CAD 5 (6%) 4 (10%) 1 (3%) 0.39 
  Three-vessel CAD 9 (12%) 7 (18%) 2 (5%) 0.18 
 Previous MI / ACS 16 (21%) 11 (28%) 5 (13%) 0.20 
 Previous PCI 19 (24%) 14 (35%) 5 (13%) 0.05 
 Previous CABG 0 (0%) 0 (0%) 0 (0%) - 
 Missing exercise test 34 (44%) 19 (48%) 15 (39%) 0.63 
 Pathological exercise test 35 (45%) 16 (40%) 19 (50%) 0.51 
 LVEF (%) 59  15 60  11 59  18 0.94 
Symptoms, n (%)     
 Angina pectoris CCS I-III 30 (38%)  21 (53%) 9 (24%) 0.02 
 Atypical chest pain 16 (20%) 5 (13%) 11 (29%) 0.13 
 Dyspnea NYHA I-III 19 (24%) 7 (18%) 12 (32%) 0.24 
 None 13 (17%) 7 (18%) 6 (16%) >0.99 
Cardiovascular risk factors, n (%)     
 Diabetes mellitus 13 (17%) 11 (28%) 2 (5%) 0.02 
 Hypertension 61 (78%) 34 (85%) 27 (71%) 0.22 
 Dyslipidemia 40 (51%) 24 (60%) 16 (42%) 0.18 
 Current or former smokers 40 (51%) 25 (63%) 15 (39%) 0.07 
Unknown CAD 59 (76%) 26 (65%) 33 (87%) 0.03 
 CAD pretest likelihood (%)† 75 ± 26 86 ± 16 66 ± 30 <0.01 
 Framingham risk score 12  9 15  9 10  7 0.01 
 
Data not given in n (%) is shown as mean  SD. *P-value for comparison of Revasc vs. Medical group. 
Revasc group, group of patients undergoing coronary revascularization; †Pretest likelihood for CAD 
was calculated according to Diamond and Forrester (Ref 18). Medical group, group of patients treated 
conservatively; CAD, coronary artery disease; MI, myocardial infarction; ACS, acute coronary 
syndrome; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; LVEF, left 
ventricular ejection fraction as assessed with gated SPECT; CCS, canadian cardiac society; NYHA, 
New York Heart Association.  
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Table 2 Imaging Results 
 All patients  
(n = 78) 
Revasc group
(n = 40) 
Medical group 
(n = 38) 
p-value* 
CTA results     
 Coronary Calcium score (ASE) † 370  
(100, 915) 
529  
(193, 1432) 
156  
(1, 586) 
0.001 
 Patients with CTA stenoses, n (%) 46 (59%) 39 (98%) 7 (18%) <0.001 
  LMA stenoses 0 (0%) 0 (0%) 0 (0%) - 
  LAD stenoses 33 (42%) 30 (75%) 3 (8%) <0.001 
  LCX stenoses 28 (36%) 25 (63%) 3 (8%) <0.001 
  RCA stenoses 30 (38%) 26 (65%) 4 (11%) <0.001 
MPI results     
 Fixed perfusion defects 13 (17%) 9 (23%) 4 (11%) 0.27 
 Reversible and partially reversible 
perfusion defects 
20 (26%) 20 (50%) 0 (0%) <0.001 
 Normal MPI perfusion 47 (60%) 13 (33%) 34 (89%) <0.001 
QCA results     
 Patients with QCA stenoses, n (%) 49 (63%) 40 (100%) 9 (24%) <0.001 
  LMA stenoses 1 (1%) 1 (3%) 0 (0%) 0.33 
  LAD stenoses 33 (42%) 27 (68%) 6 (16%) <0.001 
  LCX stenoses 29 (37%) 28 (70%) 1 (3%) <0.001 
  RCA stenoses 29 (37%) 26 (65%) 3 (8%) <0.001 
Combination CTA/MPI: flow-limiting 
stenoses 
19 (24%) 19 (48%) 0 (0%) <0.001 
Combination QCA/MPI: flow-limiting 
stenoses 
19 (24%) 19 (48%) 0 (0%) <0.001 
 
*p-value for comparison of Revasc vs. Medical group.  †data for coronary calcium score is given as 
median and interquartile range an comparison performed using Mann-Whitney U test. Revasc group, 
group of patients undergoing coronary revascularization; Medical group, group of patients treated 
conservatively; CTA, CT angiography; ASE, Agatston score equivalents; LMA, left main artery; LAD, 
left anterior descending artery; LCX, left circumflex artery; RCA, right coronary artery; MPI, myocardial 
perfusion imaging; QCA, quantitative coronary angiography 
 
 
 
 
Table 3 Univariate Predictors of Revascularization 
 OR (95% CI) p-value* 
Clinical characteristics   
 Age (years) 1.04 (0.98–1.09) 0.18 
 History of CAD 3.55 (1.13–11.15) 0.03 
 Previous MI / ACS 2.50 (0.78–8.06) 0.12 
 Pathological exercise test 0.67 (0.27–1.64) 0.38 
 LVEF (%) 1.00 (0.97–1.03) 0.94 
Symptoms   
 Angina pectoris CCS I-III 3.56 (1.35–9.41) 0.01 
 Atypical chest pain 0.35 (0.11–1.13) 0.08 
 Dyspnea NYHA I-III 0.46 (0.16–1.33) 0.15 
 None 1.13 (0.34–3.73) 0.84 
Cardiovascular risk factors   
 Diabetes mellitus 6.83 (1.40–33.28) 0.02 
 Hypertension 2.31 (0.76–7.05) 0.14 
 Dyslipidemia 2.06 (0.84–5.09) 0.12 
 Current or former smoker 2.56 (1.03–6.37) 0.04 
OR, odds ratio; CI, confidence interval; CAD, coronary artery disease; MI, 
myocardial infarction; ACS, acute coronary syndrome; LVEF, left ventricular 
ejection fraction 
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Figure legends 
 
Figure 1. Diagnostic and treatment algorithm. A flow-limiting coronary stenosis (third 
row) was defined in the presence of angiographically significant stenoses (first row) 
and evidence of ischemia on myocardial perfusion imaging (second row). Only flow-
limiting coronary stenoses were considered an indication for revascularization (fourth 
row).    
Figure 2. Myocardial perfusion SPECT after pharmacological stress (A) and at rest 
(B) showing a reversible anterior perfusion defect (ischemia). The CT angiography 
multiplanar reconstruction of the left anterior descending artery (LAD) (C) shows 
three serial stenoses of (arrows) confirmed by conventional coronary angiography (D, 
arrows). (E) Three-dimensional SPECT/CT fusion images visualize matching of LAD 
stenoses (arrows) and anterior ischemia.  
Figure 3. Classification of patients (A. patient-based analysis) and coronary arteries 
(B. vessel-based analysis) according to the presence or absence of flow-limiting 
stenoses on the combination of CTA and MPI (CTA/MPI, empty bars) or QCA and 
MPI (QCA/MPI, filled bars) and the treatment strategy (Revasc = coronary 
revascularization; Medical = conservative treatment). 
Figure 4. Example of a patient with non-flow-limiting stenoses undergoing 
revascularization. (A) Myocardial perfusion SPECT shows no significant perfusion 
defects during vasodilator stress or at rest. (B) The 3D SPECT/CT fusion images 
depict stenoses in the proximal, mid, and distal left anterior descending artery (LAD) 
(arrows). Invasive coronary angiography prior (C) and after PCI (D) document 
stenting of the mid and distal LAD lesions (arrows). The proximal LAD lesion was left 
untreated.  
